ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,539,000 | +3.1% | 1,100,000 | 0.0% | 1.58% | -13.0% |
| Q2 2023 | $21,857,000 | +16.0% | 1,100,000 | 0.0% | 1.81% | -18.1% |
| Q1 2023 | $18,843,000 | -12.5% | 1,100,000 | 0.0% | 2.21% | -1.7% |
| Q4 2022 | $21,527,000 | +34.9% | 1,100,000 | +10.0% | 2.25% | +47.5% |
| Q3 2022 | $15,953,000 | +15.9% | 999,588 | -0.0% | 1.53% | +14.8% |
| Q2 2022 | $13,760,000 | -13.2% | 1,000,000 | 0.0% | 1.33% | -13.0% |
| Q1 2022 | $15,860,000 | -27.3% | 1,000,000 | 0.0% | 1.53% | -22.9% |
| Q4 2021 | $21,830,000 | -27.0% | 1,000,000 | 0.0% | 1.98% | +39.7% |
| Q3 2021 | $29,890,000 | -32.5% | 1,000,000 | 0.0% | 1.42% | -38.7% |
| Q2 2021 | $44,290,000 | – | 1,000,000 | – | 2.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 523,280 | $10,722,007 | 12.30% |
| RTW INVESTMENTS, LP | 17,687,772 | $362,422,448 | 7.65% |
| Logos Global Management LP | 1,975,000 | $40,467,750 | 5.40% |
| ACUTA CAPITAL PARTNERS, LLC | 362,000 | $7,417,380 | 4.97% |
| New Leaf Venture Partners, L.L.C. | 118,242 | $2,422,779 | 3.11% |
| MAVERICK CAPITAL LTD | 5,629,970 | $115,358,085 | 2.60% |
| Ghost Tree Capital, LLC | 295,000 | $6,044,550 | 1.99% |
| Frazier Life Sciences Management, L.P. | 1,403,013 | $28,747,736 | 1.91% |
| Ikarian Capital, LLC | 654,726 | $13,415,335 | 1.61% |
| Boxer Capital, LLC | 1,466,051 | $30,039,385 | 1.60% |